We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$9.16B
1-Year Est. Return
63.5%
This Fund
S&P 500
This Quarter
Est. Return
+3.16%
1 Year Est. Return
+63.5%
3 Year Est. Return
+138.65%
5 Year Est. Return
+164.85%
10 Year Est. Return
+779.36%
AUM
$4.27B
AUM Growth
-$156M
(-3.5%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-5.3%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
747
New
35
Increased
227
Reduced
378
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$7.1M |
| 2 |
CUB
Cubic Corporation
CUB
|
+$6.79M |
| 3 |
Dow Inc
DOW
|
+$6.17M |
| 4 |
Boeing
BA
|
+$5.11M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$29.4M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$26.5M |
| 3 |
IDTI
Integrated Device Technology I
IDTI
|
+$16.8M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$10.5M |
| 5 |
Royal Caribbean
RCL
|
+$8.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Miscellaneous | 14.08% |
| 3 | Healthcare | 14.02% |
| 4 | Communication Services | 13.38% |
| 5 | Industrials | 12% |
Similar funds
UBP
HI
FT
SF
CL
KPWS
CCM
CLOS
Pinnacle Associates's Q2 2019 Portfolio in Review
As of Q2 2019, Pinnacle Associates held 747 positions worth $4.27B, down 3.5% from $4.43B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pinnacle Associates withdrew a net $226M in Q2 2019, closing 43 positions and reducing 378 holdings. Its most notable exit was ARRIS International plc Ordinary Shares, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, Pinnacle Associates opened a new position in Dow Inc worth $5.76M.
- Pinnacle Associates's largest Q2 2019 buy was Dow Inc: 116,842 shares worth $5.76M.
- Pinnacle Associates added most to Constellation Brands in Q2 2019, an estimated $7.1M increase.
- Pinnacle Associates's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $26.5M.
- Pinnacle Associates fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $29.4M.
- Pinnacle Associates's ten largest holdings make up 15% of its $4.27B portfolio in Q2 2019.
- Pinnacle Associates opened 35 new positions and closed 43 in Q2 2019.
- Pinnacle Associates's portfolio value fell 3.5% quarter-over-quarter to $4.27B.
Based on Pinnacle Associates's 13F filing for Q2 2019, filed 5 Aug 2019.